scholarly article | Q13442814 |
P356 | DOI | 10.1124/MOL.51.2.193 |
P698 | PubMed publication ID | 9203623 |
P50 | author | Len Neckers | Q89479068 |
P2093 | author name string | Curt G | |
Bergan R | |||
Kyle E | |||
Takimoto C | |||
P433 | issue | 2 | |
P304 | page(s) | 193-200 | |
P577 | publication date | 1997-02-01 | |
P1433 | published in | Molecular Pharmacology | Q1943386 |
P1476 | title | Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity | |
P478 | volume | 51 |
Q36054603 | Can a single model explain both breast cancer and prostate cancer? |
Q33247276 | Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification |
Q80297993 | Complementary medicine for prostate cancer: effects of soy and fat consumption |
Q39626106 | Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression |
Q34386003 | Dietary agents in cancer prevention: flavonoids and isoflavonoids. |
Q30304050 | Differentiating agents and nontoxic therapies |
Q36740123 | Effects of soy phytoestrogens on the prostate |
Q33843334 | Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation |
Q52542857 | Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation. |
Q37618157 | Genistein as a Potential Anticancer Agent against Ovarian Cancer. |
Q38948380 | Genistein decreases cellular redox potential, partially suppresses cell growth in HL‑60 leukemia cells and sensitizes cells to γ‑radiation‑induced cell death |
Q38215654 | Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis |
Q40327067 | Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis |
Q33241207 | Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest |
Q33837460 | Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis |
Q28571929 | H(2)O(2)-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells |
Q47349234 | In the prostatic epithelium, dietary isoflavones from red clover significantly increase estrogen receptor beta and E-cadherin expression but decrease transforming growth factor beta1. |
Q34049121 | In vitro effects of polyphenols on colorectal cancer cells |
Q36437897 | Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies |
Q77787501 | Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein |
Q34105995 | Inhibition of cancer cell invasion and metastasis by genistein |
Q35763101 | Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention? |
Q33582732 | LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method |
Q46734504 | Local calcium transients contribute to disappearance of pFAK, focal complex removal and deadhesion of neuronal growth cones and fibroblasts. |
Q37309967 | MEK4 function, genistein treatment, and invasion of human prostate cancer cells |
Q36955543 | Multi-targeted therapy of cancer by genistein |
Q37181478 | Natural isoflavones regulate the quadruplex-duplex competition in human telomeric DNA |
Q33653636 | Nutrition and prostate cancer |
Q38360560 | Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion |
Q37207772 | Perspectives on the role of isoflavones in prostate cancer |
Q36409219 | Phenoxodiol: isoflavone analog with antineoplastic activity |
Q74345767 | Phyto-oestrogens through the life cycle |
Q53384314 | Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells. |
Q34563981 | Radiosensitization in prostate cancer: mechanisms and targets |
Q40792300 | Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated protein kinases as potential drug discovery targets |
Q40937374 | Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells |
Q34613013 | Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin |
Q34707481 | The role of complementary medicine in the treatment of prostate cancer |
Q34729838 | The role of soy phytoestrogens in prostate cancer |
Q35741691 | The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages |
Q43570319 | Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer |
Search more.